In 2024, I joined Fast Company's Executive Board and began writing articles about healthcare and technology. I've written about Longevity and last week, I wrote my predictions for health AI in 2025. I'm including the...

While this has been a very turbulent year in all manners of speaking, for health technology it has been a rather eventful year and mostly positive. While the world has been dealing with major geopolitical...

As we discussed in the last post in this series, there are new developments in the regulation of health AI products. While the FDA is one key body in clearing these solutions for their efficacy...

In the last post, I discussed how a lower bar for clearing AI products by the FDA has not led to the faster adoption of these products by the medical community and in fact, it...

While there has been an explosion of FDA-approved health AI products, most have not yet gained much traction in the everyday clinical workflows. There are several reasons for this. First, it's important to understand the...

In the final post in this series, I'll discuss the approaches that can make a very necessary and tedious part of administering healthcare more automated and where it can go from here. If you examine...